版权说明 操作指南
首页 > 成果 > 详情

Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Yu, X.;Zhu, F.;Wang, J.;Wu, B.*;Li, C.*
通讯作者:
Wu, B.;Li, C.
作者机构:
[Li, C.; Yu, X.; Wu, B.; Wu, B; Li, C] Chongqing Hosp Tradit Chinese Med, Basic Res Dept Tradit Chinese Med & Pharm, Chongqing 400021, Peoples R China.
[Li, C.; Wu, B.; Wang, J.; Zhu, F.] Chongqing Hosp Tradit Chinese Med, Dept Rheumatol, Chongqing 400021, Peoples R China.
[Yu, X.] Hunan Univ Tradit Chinese Med, Grad Sch, Changsha, Peoples R China.
通讯机构:
[Wu, B; Li, C] C
Chongqing Hosp Tradit Chinese Med, Basic Res Dept Tradit Chinese Med & Pharm, Chongqing 400021, Peoples R China.
语种:
英文
期刊:
Scandinavian Journal of Rheumatology
ISSN:
0300-9742
年:
2023
卷:
52
期:
2
页码:
200-207
机构署名:
本校为其他机构
院系归属:
研究生院
摘要:
OBJECTIVE: The aim of this study was to explore the significance of serum CCL28 in Sjögren's syndrome (SS) diagnosis and evaluation. METHOD: The expression of CCL28 mRNA in salivary glands of SS patients from the GEO database was analysed. Serum levels of CCL28 of SS patients, rheumatoid arthritis (RA) patients, systemic lupus erythematosus (SLE) patients, and healthy controls (HCs) were measured by enzyme-linked immunosorbent assay. The serum immunoglobulin A (IgA) levels and the focus score of labial salivary gland (LSG) in patients with SS ...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com